Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Analysis of glioblastoma patients' plasma revealed the presence of microRNAs with a prognostic impact on survival and those of viral origin
Authors:ID Zupančič, Klemen (Author)
ID Motaln, Helena (Author)
ID Knežević, Miomir (Author)
ID Verbovšek, Urška (Author)
ID Koršič, Marjan (Author)
ID Lah Turnšek, Tamara (Author)
ID Rožman, Primož (Author)
ID Jeras, Matjaž (Author)
ID Hren, Matjaž (Author)
ID Gruden, Kristina (Author)
ID Blejec, Andrej (Author)
ID Veber, Matija (Author)
ID Herman, Ana (Author)
ID Porčnik, Andrej (Author)
ID Podpečan, Vid (Author)
Files:URL URL - Presentation file, visit http://dx.doi.org/10.1371/journal.pone.0125791
 
.pdf PDF - Presentation file, download (2,99 MB)
MD5: 96193B6D6A15E0E2038980E47FF44FC8
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo NIB - National Institute of Biology
Abstract:Background Glioblastoma multiforme (GBM) is among the most aggressive cancers with a poor prognosis in spite of a plethora of established diagnostic and prognostic biomarkers and treatment modalities. Therefore, the current goal is the detection of novel biomarkers, possibly detectable in the blood of GBM patients that may enable an early diagnosis and are potential therapeutic targets, leading to more efficient interventions. Experimental Procedures MicroRNA profiling of 734 human and human-associated viral miRNAs was performed on blood plasma samples from 16 healthy individuals and 16 patients with GBM, using the nCounter miRNA Expression Assay Kits. Results We identified 19 miRNAs with significantly different plasma levels in GBM patients, compared to the healthy individuals group with the difference limited by a factor of 2. Additionally, 11 viral miRNAs were found differentially expressed in plasma of GBM patients and 24 miRNA levels significantly correlated with the patients’ survival. Moreover, the overlap between the group of candidate miRNAs for diagnostic biomarkers and the group of miRNAs associated with survival, consisted of ten miRNAs, showing both diagnostic and prognostic potential. Among them, hsa miR 592 and hsa miR 514a 3p have not been previously described in GBM and represent novel candidates for selective biomarkers. The possible signalling, induced by the revealed miRNAs is discussed, including those of viral origin, and in particular those related to the impaired immune response in the progression of GBM. Conclusion The GBM burden is reflected in the alteration of the plasma miRNAs pattern, including viral miRNAs, representing the potential for future clinical application. Therefore proposed biomarker candidate miRNAs should be validated in a larger study of an independent cohort of patients
Keywords:microRNAs, glioblastoma multiforme, biomarkers, RNA extraction, viral disease diagnosis
Publication status:Published
Publication version:Version of Record
Publication date:07.05.2015
Year of publishing:2015
Number of pages:str. 1-20
Numbering:Vol. 10, iss. 5
PID:20.500.12556/DiRROS-6097 New window
ISSN:1932-6203
UDC:577.21
DOI:10.1371/journal.pone.0125791 New window
COBISS.SI-ID:3453007 New window
Publication date in DiRROS:26.07.2024
Views:362
Downloads:162
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Document is financed by a project

Funder:Other - Other funder or multiple funders
Funding programme:BioSistemika, Educell Ltd and Celica

Back